Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
about
Interrupted time-series analysis of regulations to reduce paracetamol (acetaminophen) poisoningAcetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdoseMechanisms of acetaminophen-induced liver necrosisIntravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.Acute liver failure including acetaminophen overdoseStem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized studyComparison of Bile Acids and Acetaminophen Protein Adducts in Children and Adolescents with Acetaminophen ToxicityHepatoprotective activity of Mammea africana ethanol stem bark extractProtein damage by reactive electrophiles: targets and consequencesAssociation of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury.Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology.Targeted liquid chromatography-mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children.Mechanisms of drug-induced liver injury: from bedside to bench.Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome.HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicityArgininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humansLower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase.Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failureThe proper use of acetaminophen.Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury.Confirming the Causative Role of Acetaminophen in Indeterminate Acute Liver Failure Using Acetaminophen-Cysteine Adducts.Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witnessThe mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.Translational biomarkers of acetaminophen-induced acute liver injuryTime course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells.Acute liver failure: Summary of a workshopTarget biomarker profile for the clinical management of paracetamol overdose.Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity.Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial.Recent developments in acute liver failureParacetamol (acetaminophen) protein adduct concentrations during therapeutic dosing.Chronic acetaminophen exposure in pediatric acute liver failure.Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products.Hepatoprotective Activity of Herbal Composition SAL, a Standardize Blend Comprised of Schisandra chinensis, Artemisia capillaris, and Aloe barbadensis.False positive acetaminophen concentrations in patients with liver injury.Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations.
P2860
Q21090141-5B34B18A-AC0F-47DD-A64B-17082445BAEBQ24624026-43B49FDE-F01B-4C94-8EC1-86F0FA32810EQ24629891-60D0467A-F058-4C53-B953-121DB9FA098DQ24635175-45B61B4C-2DC8-44A9-B0B9-DC23735B4D03Q24647134-1EE341C4-9711-49F1-9439-3661BA9784D0Q27024267-072BA2AE-EE92-43C4-888B-E9508C744860Q27690772-366CC541-393A-4B50-B7AB-34F3ECAB0AF2Q28211832-E2118DB0-6591-4A75-8306-B118648A89D0Q28546783-4AE0A3D3-C50F-43B0-879C-047BEC609DF4Q28833598-79081AD9-3DB6-49B6-9F02-8478C5F69E45Q33308185-244E01E2-E814-4134-8C1B-7089ECB00F3FQ33600448-760564EA-86EB-4561-8001-554409DEC199Q33845461-E35CD8CF-25E6-4DBE-9012-422C66810788Q33848167-FE917F68-43E8-4424-937D-E0708709C3DAQ34015035-E38F99E1-AB9B-474F-8426-23914CB437A0Q34169362-65684A0B-9588-4A43-AE94-3019363D6646Q34225946-C7F55849-1334-4120-B0AE-BCBAC6A5333EQ34241967-8C4F346C-E0DB-427C-8F0E-2B9485102961Q34775607-15F641B1-42A8-466B-81D7-B7323AFF2CC8Q34794994-46A9387C-C366-4A8E-8CBF-C73F629672ABQ35185719-091925B2-F998-4E69-8101-68DD6C519C66Q35529749-E0C12860-0C36-46F0-8B51-27C8DE831778Q35572609-C493BEDC-A518-4765-8C58-D1ED545D3202Q35648831-B80DFDDC-E63B-4484-B8ED-ED8760DB2FA7Q35749121-E9825EB4-C6D9-47D6-BF7C-EB0F532761AAQ35796397-3D278567-FC6D-40C8-9A40-3FA238045F68Q35858082-5330CFFC-11C9-464D-AD12-A471A1AA4382Q36001451-2280CEFA-83F9-4F84-938D-3DBA93A102EDQ36005892-06710C98-1812-4EEA-9DB6-03A6F3612F88Q36054934-A5E586A9-1351-4F08-9EEE-FBB4D42877C5Q36072453-AD3CBA44-D4C9-4A6F-8B95-94194898CA35Q36339274-3ACE6531-DC61-4427-9DF7-7BAB00FA59C1Q36431416-03ACE4E8-6B3D-4259-9782-85EAA58E1C15Q36551050-D0DCA3E1-A337-4FA4-B0A0-41990D04CA0DQ36618136-115AE4F3-1146-4B4C-9E3C-B7ED59ED62BBQ36637082-63768AFC-4AA7-4DA9-86D5-2B82F3CBC932Q36718265-50AB8819-7F41-4DEB-909B-FC0BBCF89796Q36737840-07AEC6FA-3B6D-4540-9995-9B0E555B537EQ36746440-FC98C24D-442B-4AAF-8682-C338D646EA29Q36759456-3D41D472-79CF-4CCE-B0F4-CD00A1B108AE
P2860
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
@en
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
@nl
type
label
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
@en
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
@nl
prefLabel
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
@en
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
@nl
P2093
P1433
P1476
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
@en
P2093
A Obaid Shakil
Acute Liver Failure Study Group
Anne M Larson
Ezmina Lalani
Jack A Hinson
Julie Polson
Laura P James
Robert J Fontana
Santiago Munoz
Timothy J Davern
P304
P356
10.1053/J.GASTRO.2006.01.033
P407
P577
2006-03-01T00:00:00Z